[Federal Register Volume 65, Number 104 (Tuesday, May 30, 2000)]
[Notices]
[Pages 34498-34499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-13435]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 10, 2000, and published in the Federal 
Register on February 17, 2000, (65 FR 8207), Noramco of Delaware, Inc., 
Division of McNeilab, Inc., which has changed its name to Noramco of 
Delaware, Inc., Division of Ortho-McNeil, Inc., 500 Old Swedes Landing 
Road, Wilmington, Delaware 19801, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050).............................  II
Oxycodone (9143)...........................  II

[[Page 34499]]

 
Hydrocodone (9193).........................  II
Morphone (9300)............................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers as bulk product.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Noramco of 
Delaware, Inc. to manufacture the listed controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Noramco of Delaware, Inc. on a regular basis to ensure that the 
company's continued registsration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
above is granted.

    Dated: May 19, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-13435 Filed 5-26-00; 8:45 am]
BILLING CODE 4410-09-M